Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROMA: Rosuvastatin Pretreatment in Elective PCI
NCT01007279Phase 3Completed
- Sponsor
- Sapienza University of Rome
- Start
- Mar 2010
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rosuvastatin in myocardial infarction (MI) (2 arms), sponsored by Sapienza University of Rome. Primary endpoint: Incidence of Periprocedural Myocardial Necrosis at 24 hours. Started Mar 2010; status: completed.
02
Drugs
rosuvastatin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01007279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007279.